Carvedilol
Product Images NDC 0781-5221

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 0781-5221). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Image 01)

Structure (Image 01)
Chemical structure of Carvedilol, showing its molecular arrangement with multiple ring systems and functional groups including ethers and amines, as depicted in the Sandoz Inc product image.*
FDA Label Image

Figure 1 (Image 02)

Figure 1 (Image 02)
A line graph comparing mortality percentage over approximately 22 months between two groups labeled Placebo and Carvedilol. The vertical axis shows % Mortality, and the horizontal axis shows time in months. The Carvedilol group shows consistently lower mortality than the Placebo group. A p-value of 0.0014 is noted on the graph.*
FDA Label Image

Figure 2 (Image 03)

Figure 2 (Image 03)
A forest plot depicting hazard ratios across various patient subgroups including gender, age, race, diabetic and ischemic status, heart rate, systolic blood pressure, and spironolactone use. The plot shows the point estimates with confidence intervals relative to a hazard ratio scale from 0 to 2.*
FDA Label Image

Figure 3 (Image 04)

Figure 3 (Image 04)
A line graph depicting total mortality percentage over 24 months comparing Carvedilol and placebo. The x-axis represents time in months, while the y-axis shows percent total mortality. The graph indicates lower mortality with Carvedilol compared to placebo, with a reported p-value of 0.03.*
FDA Label Image

Figure 4 (Image 05)

Figure 4 (Image 05)
A forest plot displaying hazard ratios for different subgroups related to Carvedilol treatment. It compares variables such as age, gender, timing post-myocardial infarction, prior beta-blocker use, Killip class, thrombolytic therapy, PTCA, heart failure, diuretics use, angina, hypertension, diabetes, heart rate, and systolic blood pressure. Each group's point estimate and confidence intervals are shown relative to a hazard ratio of 1.0.*
FDA Label Image

3.125 mg Label (Image 06)

3.125 mg Label (Image 06)
Carvedilol Tablets, USP 3.125 mg label from Sandoz Inc. The label states the strength as 3.125 mg per tablet and indicates a quantity of 100 tablets. Additional information includes dosage storage instructions, manufacturer details, and a barcode on the right side.*
FDA Label Image

6.25 mg Label (Image 07)

6.25 mg Label (Image 07)
Carvedilol Tablets, USP 6.25 mg film-coated tablets labeled for prescription use, with a package count of 100 tablets. The label shows storage instructions and manufacturer details indicating production by Sandoz Private Ltd for Sandoz Inc. The label includes the NDC 0781-5222-01 and emphasizes child safety and proper storage.*
FDA Label Image

12.5 mg Label (Image 08)

12.5 mg Label (Image 08)
Carvedilol Tablets, USP 12.5 mg label from Sandoz Inc. The label shows the product name, strength, dosage form, quantity of 100 tablets, and storage instructions. It includes the NDC number 0781-5223-01 and states the product is Rx only, manufactured in India by Sandoz Private Ltd for Sandoz Inc, Princeton, NJ.*
FDA Label Image

25 mg Label (Image 09)

25 mg Label (Image 09)
Label for Carvedilol Tablets USP 25 mg by Sandoz Inc. The label states the product contains 100 film-coated tablets, prescription only. Storage instructions include keeping at 20° to 25°C (68° to 77°F) and protecting from moisture. Manufactured by Sandoz Private Ltd for Sandoz Inc, Princeton, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.